Pilot study evaluating the efficacy of MitoQ in adults with type II diabetes and coronary vascular disease.
Not Applicable
Not yet recruiting
- Conditions
- DiabetesCoronary vascular disease.
- Registration Number
- ACTRN12617000293369
- Lead Sponsor
- niversity of Auckland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does MitoQ target to improve endothelial function in type II diabetes and coronary vascular disease?
How does MitoQ's efficacy compare to standard-of-care treatments for endothelial dysfunction in diabetic patients with coronary vascular disease?
Which biomarkers are associated with response to MitoQ in patients with type II diabetes and coronary vascular disease?
What are the potential adverse events of MitoQ in adults with type II diabetes and coronary vascular disease and how can they be managed?
Are there any combination therapies or competitor drugs that enhance mitochondrial function in type II diabetes and coronary vascular disease similar to MitoQ?